Connected Drug Injection Devices to 2020

Dublin, March 24, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/jjc7rt/connected_drug) has announced the addition of the "Connected Drug Injection Devices" report to their offering.

Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.

For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life. Connected devices - drug injection devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs - are gaining interest among industry and managed care participants.

What You Will Learn

- What drug injection devices incorporate wireless connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?
- What benefits do connected drug injectors provide to patients in the area of improved adherence? Patient reported outcomes? HCP/patient communication?
- What therapeutic areas are the current focus of connected devices?
- Who are the companies behind the push to connected injection devices? What are their development activities and corporate alliances and affiliations
- What is the importance of pharma-device alliances and design partnerships on connected drug injection device commercialization and market access?
- What does the current market for connected drug injection devices look like? What will it look like in 2020?
- What are the key market drivers for the growth of connected injection devices?

Who Should Read This Report

Development:

- Drug Developers
- Device Suppliers
- CMOs
- Components/APIs
- Testing/Validation
- Clinical Trial Mgmt

Industry:

- Pharma Managers
- Biotech Managers
- Drug Marketers
- Industry Strategists
- Financial Analysts
- Management
- Consultants

Market:

- Clinical Managers
- Drug Distributors
- Pharma Regulators
- FDA Consultants
- Managed Care Managers

Key Topics Covered:

1. Executive Summary

2. Connected Devices - The Opportunity
- Injectable Drug Development Trends
- The Rapid Rise of Prefilled Injection Devices
- Factors Driving Drug Self-Administration
- Therapeutic Demand Drivers
- The Impact of Developing Economies

3. Connectivity Technologies
- Wireless Technologies
- Bluetooth
- Cellular
- Near Field Communications
- Wired Technologies

4. Connected Devices

5. Wearable Devices
- Connected Autoinjectors
- Non-drug Specific Connected Injectors
- Self-powered Devices
- Automated Connected Injectors
- Vendor-specific Connectivity Platforms

6. Third Party Connectivity Devices

7. Near-term Markets for Connected Injection Devices
- Anaphylaxis
- Autoimmune Disease
- Cardiovascular
- Diabetes
- Hormone Replacement

8. Market Factors
- Regulatory Requirements
- Data Security
- Patient Acceptance

9. Company Profiles

For more information visit http://www.researchandmarkets.com/research/jjc7rt/connected_drug

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Infusions and Injectables , Needles and Syringes